pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,833 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT875Endpoints679BioPharma Dive255onclive165BioSpace128Fierce Biotech119globenewswire health46raps
therapy area
allOncology5255Rare Disease982Cardiology911Hematology814Immunology792Pulmonology650Psychiatry & CNS
  • Call to unify MD and DO medical education pathways
    Physicians Abigail MacKenzie and Vijay Rajput argue that keeping medical education split between allopathic (MD) and osteopathic (DO) tracks is an outdated practice that adds no value to patient ca…
    STAT · 18h agoPositive↗ source
  • Schrödinger CEO Ramy Farid rethinks role of AI in drug discovery
    In a recent STAT AI Prognosis newsletter, Schrödinger chief executive Ramy Farid discussed how his perspective on artificial intelligence is evolving. He reflected on recent conversations about AI…
    STAT · 13h agoNeutral↗ source
← prev
page 2 of 74
next →
46
fda recalls31
fda press22
fda medwatch21
627
Vaccines544
Endocrinology & Metabolism308
Ophthalmology283
Infectious Disease271
Pain270
Alphabet reshuffles AI leadership as DeepMind CEO steps down to become chief scientist
Alphabet announced a reorganization of its artificial intelligence leadership. Demis Hassabis will leave his role as chief executive of Google DeepMind and take on the position of chief scientist f…
Endpoints · 9h agoNeutral↗ source
  • Danske Bank corrects placement of English PDF in transaction disclosure
    The bank originally posted a notice that attached both the Danish and English PDF files to the Danish version of its website. A correction has now moved the English PDF to the English version of th…
    globenewswire health · 16h agoRegulatoryNeutral↗ source
  • Opinion: Films on assisted dying often ignore socioeconomic factors as New York law takes effect
    The piece, authored by Anna Magdalena Elsner and Vanessa Rampton, notes that New York's Medical Aid in Dying Act will become law on Aug 5, 2026, marking a major policy shift for terminally ill pati…
    STAT · 18h agoNeutral↗ source
  • AL Sydbank reports insider share transactions by senior staff and relatives
    AL Sydbank issued a corporate announcement on 5 August 2026, disclosing share transactions made by its senior employees and their close relatives. The disclosure is made in compliance with Article…
    globenewswire health · 17h agoRegulatoryNeutral↗ source
  • AL Sydbank reports manager and associate share transactions under Market Abuse Regulation
    AL Sydbank has issued a company announcement detailing recent share transactions carried out by its managers and individuals closely linked to them. The disclosure is made under Article 19 of the…
    globenewswire health · 17h agoRegulatoryNeutral↗ source
  • Danske Bank corrects webpage to place English PDF under English version for share buy-back disclosure
    A correction notice was issued for Danske Bank A/S regarding the placement of an English PDF on its website. The original posting had both Danish and English PDFs attached under the Danish version…
    globenewswire health · 16h agoNeutral↗ source
  • Novo Nordisk eyes bolt-on deals as pipeline disappointments pile up
    “If you don't like setbacks and you don't like failure, don't get into the pharma industry,” Novo Nordisk CEO Maziar Mike Doustdar said on a call with media Wednesday. The implication was unintende…
    Endpoints · 16h ago↗ source
  • RETTELSE -- Danske Bank A/S, ledende medarbejderes transaktioner
    I den oprindelige meddelelse var både den danske og den engelske PDF-fil vedhæftet under den danske version på websiden. Med denne rettelse er den engelske PDF-fil nu flyttet til den engelske versi…
    globenewswire health · 16h ago↗ source
  • CORRECTION -- Danske Bank A/S, transactions by persons discharging managerial responsibilities
    In the original notification, the Danish and English PDF files were both attached under the Danish version on the webpage. With this correction, the English PDF has now been moved to the English ve…
    globenewswire health · 16h ago↗ source
  • RETTELSE -- Danske Bank A/S, ledende medarbejderes transaktioner
    I den oprindelige meddelelse var både den danske og den engelske PDF-fil vedhæftet under den danske version på websiden. Med denne rettelse er den engelske PDF-fil nu flyttet til den engelske versi…
    globenewswire health · 16h ago↗ source
  • CORRECTION -- Danske Bank A/S, transactions by persons discharging managerial responsibilities
    In the original notification, the Danish and English PDF files were both attached under the Danish version on the webpage. With this correction, the English PDF has now been moved to the English ve…
    globenewswire health · 16h ago↗ source
  • STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
    Excluding rare disease therapies from a Medicare pilot program to lower drug prices would wipe out much of the savings from retail drugs, according to new research.
    STAT · 18h ago↗ source
  • Danske Bank A/S, ledende medarbejderes transaktioner
    5. august 2026
    globenewswire health · 18h ago↗ source
  • Danske Bank A/S, transactions by persons discharging managerial responsibilities
    5 August 2026
    globenewswire health · 18h ago↗ source
  • Otsuka's Voyxact hits key secondary endpoint in Phase 3 IgA nephropathy trial as BioNTech cuts revenue outlook
    Otsuka announced that its experimental kidney drug Voyxact met a key secondary endpoint in the Phase 3 VISIONARY study of patients with IgA nephropathy. The positive result suggests the therapy ha…
    Endpoints · 1d agoPositive readoutNeutral↗ source
  • Pathos AI signs major ADC partnership with Chinese biotech Alphamab and targets up to $300M Series E raise
    Pathos AI, a technology and drug development company, announced a major antibody‑drug conjugate (ADC) collaboration with Chinese biotech Alphamab. The firm also disclosed a partnership with AstraZ…
    Endpoints · 2d agoDealPositive↗ source
  • Hinge Health to acquire Cylinder Health for $105 million, expanding into digestive care
    Hinge Health, known for virtual physical therapy, announced it will purchase digestive health startup Cylinder Health. The transaction is a cash deal valued at $105 million, marking Hinge's latest…
    Endpoints · 1d agoDealPositive↗ source
  • Ebola outbreak in eastern Congo kills over 1,700 as cases surge past 3,800
    The latest government report shows that the Ebola outbreak in eastern Congo has resulted in more than 1,700 deaths and a total of 3,802 recorded cases. Health officials say that about 60-70% of ne…
    STAT · 1d agoNegative↗ source
  • Pfizer CEO says company has already completed its largest deals, no further acquisitions planned
    Pfizer chief Albert Bourla addressed investors from the New York Stock Exchange floor, noting that the company has already executed its biggest transactions and has roughly $6 billion earmarked for…
    Endpoints · 1d agoDealNeutral↗ source
  • Gilead wins legal battle over HIV drug as Eli Lilly opens early access program for obesity therapy retatrutide
    Gilead Sciences secured a court victory concerning one of its HIV medicines, according to the brief report. The ruling resolves a legal dispute that had been pending, allowing the company to contin…
    STAT · 1d agoRegulatoryPositive↗ source
  • Ambient scribing startups draw attention as Abridge secures $300 million funding
    Last summer, a wave of ambient scribing startups captured the health-tech spotlight. These companies employ artificial-intelligence systems that listen to doctor-patient conversations and automati…
    Endpoints · 1d agoDealNeutral↗ source
  • UK regulator debates whether AI scribes count as medical devices
    UK regulators are examining whether AI-driven clinical documentation tools, often called AI scribes, should be classified as medical devices under current law. The proposal has generated debate am…
    STAT · 1d agoRegulatoryNeutral↗ source
  • Akido expands AI-driven patient intake and diagnostic tools to 100 clinics
    Akido, a health‑technology startup, announced it will deploy its artificial‑intelligence platform for patient intake and diagnostic assistance in 100 clinics. The AI system captures patient inform…
    Endpoints · 1d agoDealPositive↗ source